| 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis JA Singh, G Guyatt, A Ogdie, DD Gladman, C Deal, A Deodhar, ... Journal of Psoriasis and Psoriatic arthritis 4 (1), 31-58, 2019 | 824 | 2019 |
| The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) PS Helliwell, O FitzGerald, J Fransen, DD Gladman, GG Kreuger, ... Annals of the rheumatic diseases 72 (6), 986-991, 2013 | 339 | 2013 |
| International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials AM Orbai, M De Wit, P Mease, JA Shea, L Gossec, YY Leung, W Tillett, ... Annals of the rheumatic diseases 76 (4), 673-680, 2017 | 301 | 2017 |
| Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA D van der Heijde, M Dougados, R Landewé, J Sieper, WP Maksymowych, ... Rheumatology 56 (9), 1498-1509, 2017 | 115 | 2017 |
| Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V … M Dougados, JCC Wei, R Landewé, J Sieper, X Baraliakos, ... Annals of the rheumatic diseases 79 (2), 176-185, 2020 | 110 | 2020 |
| Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort JA Walsh, M McFadden, J Woodcock, DO Clegg, P Helliwell, ... Journal of the American Academy of Dermatology 69 (6), 931-937, 2013 | 89 | 2013 |
| Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE) P Nash, K Ohson, J Walsh, N Delev, D Nguyen, L Teng, JJ Gómez-Reino, ... Annals of the rheumatic diseases 77 (5), 690-698, 2018 | 85 | 2018 |
| Clinical manifestations and diagnosis of axial spondyloarthritis JA Walsh, M Magrey JCR: Journal of Clinical Rheumatology 27 (8), e547-e560, 2021 | 81 | 2021 |
| Effect of certolizumab pegol over ninety‐six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial J Sieper, R Landewe, M Rudwaleit, D Van der Heijde, M Dougados, ... Arthritis & Rheumatology 67 (3), 668-677, 2015 | 78 | 2015 |
| Work productivity loss and fatigue in psoriatic arthritis JA Walsh, ML McFadden, MD Morgan, AD Sawitzke, KC Duffin, ... The Journal of rheumatology 41 (8), 1670-1674, 2014 | 76 | 2014 |
| Recognizing axial spondyloarthritis: a guide for primary care MN Magrey, AS Danve, J Ermann, JA Walsh Mayo Clinic Proceedings 95 (11), 2499-2508, 2020 | 74 | 2020 |
| Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis JA Walsh, KC Duffin, GG Krueger, DO Clegg The Journal of rheumatology 40 (3), 287-293, 2013 | 71 | 2013 |
| Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set JA Walsh, X Song, G Kim, Y Park Clinical rheumatology 37, 1869-1878, 2018 | 66 | 2018 |
| Diagnosing and treating psoriatic arthritis: an update WH Boehncke, A Qureshi, JF Merola, D Thaçi, GG Krueger, J Walsh, ... British Journal of Dermatology 170 (4), 772-786, 2014 | 53 | 2014 |
| Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines WC Zamboni, PJ Houghton, JL Hulstein, M Kirstein, J Walsh, PJ Cheshire, ... Cancer chemotherapy and pharmacology 43, 269-276, 1999 | 53 | 1999 |
| Treatment patterns among patients with psoriatic arthritis treated with a biologic in the United States: descriptive analyses from an administrative claims database JA Walsh, O Adejoro, B Chastek, JB Palmer, P Hur Journal of managed care & specialty pharmacy 24 (7), 623-631, 2018 | 52 | 2018 |
| The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc … JA Walsh, H Jones, L Mallbris, KC Duffin, GG Krueger, DO Clegg, ... Psoriasis: Targets and Therapy, 65-74, 2018 | 48 | 2018 |
| Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006–2016 J Walsh, T Hunter, K Schroeder, D Sandoval, R Bolce BMC rheumatology 3 (1), 1581, 2019 | 44 | 2019 |
| Healthcare utilization and direct costs in patients with ankylosing spondylitis using a large US administrative claims database JA Walsh, X Song, G Kim, Y Park Rheumatology and Therapy 5, 463-474, 2018 | 36 | 2018 |
| Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors JA Walsh, KC Duffin, J Crim, DO Clegg Journal of Clinical Sleep Medicine 8 (6), 643-648, 2012 | 36 | 2012 |
Daniel O M CleggUniversity of UtahVerified email at hsc.utah.edu